Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemia

Hagop M. Kantarjian*, Moshe Talpaz, Terry L. Smith, Jorge Cortes, Francis J. Giles, Mary Beth Rios, Susie Mallard, James Gajewski, Anthony Murgo, Bruce Cheson, Susan O'Brien

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

76 Scopus citations

Fingerprint

Dive into the research topics of 'Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences